Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

New serological platform for detecting antibodies against Mycobacterium tuberculosis complex in European badgers

  • Infantes-Lorenzo, Jose Antonio
  • Dave, Dipesh
  • Moreno-Iruela, Inmaculada
  • Anderson, Paul
  • Lesellier, Sandrine
  • Gormley, Eamonn
  • Domínguez, Lucas
  • Balseiro, Ana
  • Gortázar, Christian
  • Dominguez-Rodriguez, Mercedes
  • Salguero, Francisco J
European badgers (Meles meles) have been identified as wildlife reservoirs for Mycobacterium bovis in the UK and Ireland, and may also have a role in the epidemiology of animal tuberculosis in other European regions. Thus, detection of M. bovis-infected badgers may be required for the purposes of surveillance and monitoring of disease levels in infected populations. Current serological assays to detect M. bovis infection in live badgers, while rapid and inexpensive, show limited diagnostic sensitivity. Here we describe and evaluate new ELISA platforms for the recognition of the P22 multiprotein complex derived from the purified protein derivative (PPD) of M. bovis. The recognition of IgG against P22 multiprotein complex derived from PPD-B was tested by ELISA in the serum of badgers from the UK, Ireland and Spain. TB infection in the badgers was indicated by the presence of M. bovis in tissues by culture and histology at post-mortem examination and TB-free status was established by repeated negativity in the interferon γ release assay (IGRA). In experimentally infected badgers, humoral antibody responses against P22 developed within 45 days post-infection. The ELISA tests showed estimated sensitivity levels of 74-82% in experimentally and naturally infected badgers with specificities ranging from 75% to 100% depending on the badger population tested. The P22 multi-antigen based ELISAs provide a sensitive and specific test platform for improved tuberculosis surveillance in badgers.
Repisalud
Publicación Artículo científico (JournalArticle)

Development and Evaluation of a Serological Assay for the Diagnosis of Tuberculosis in Alpacas and Llamas

  • Infantes-Lorenzo, Jose Antonio
  • Whitehead, Claire E
  • Moreno-Iruela, Inmaculada
  • Bezos, Javier
  • Roy, Álvaro
  • Domínguez, Lucas
  • Dominguez-Rodriguez, Mercedes
  • Salguero, Francisco J
South American camelids are susceptible to tuberculosis, caused mainly by Mycobacterium bovis and M. microti. Despite the tuberculin skin test being the official test for tuberculosis, it has a very low sensitivity in these species (14-20%). Serological tests present the advantages of being rapid, easy to perform and facilitate analysis of large numbers of samples in a short period of time. Novel antigen discovery and evaluation would provide enhanced detection of specific antibodies against members of M. tuberculosis complex. Here, we describe the development and evaluation of an ELISA-type immunoassays to use in the diagnosis of tuberculosis in llamas and alpacas based on P22, a multiprotein complex obtained by affinity chromatography from bovine Purified Protein Derivative (bPPD), that showed high sensitivity and specificity in mice, cattle and goats. This work was performed in two stages. First, a preliminary panel of samples collected from tuberculosis-free (n = 396) and M. bovis-infected herds (n = 56) was assayed, obtaining high specificity (100%) and sensitivity ranging from 63 to 96%. Subsequently, the use of the serological assay was tested using samples from two herds suffering from clinical M. bovis (n = 88) and M. microti (n = 25) infection to evaluate the ability of the ELISA to detect infected animals. 11 out of 88 alpacas were positive to the ELISA in a M. bovis outbreak and 7 out of 25 in a M. microti outbreak. The P22 ELISA potentially provides a sensitive and specific platform for improved tuberculosis surveillance in camelids.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The earliest basketry in southern Europe: Hunter-gatherer and farmer plant-based technology in Cueva de los Murciélagos (Albuñol)

  • Martínez-Sevilla, Francisco
  • Herrero-Otal, María
  • Martín-Seijo, María
  • Santana, Jonathan
  • Lozano Rodríguez, José Antonio
  • Maicas Ramos, Ruth
  • Cubas, Miriam
  • Homs, Anna
  • Martínez Sánchez, Rafael M.
  • Bertin, Ingrid
  • Barroso Bermejo, Rosa
  • Bueno Ramírez, Primitiva
  • Balbín Behrmann, Rodrigo de
  • Palomo Pérez, Antoni
  • Álvarez-Valero, Antonio M.
  • Peña-Chocarro, Leonor
  • Murillo-Barroso, Mercedes
  • Fernández-Domínguez, Eva
  • Altamirano García, Manuel
  • Pardo Martínez, Rubén
  • Iriarte Cela, Mercedes
  • Carrasco Rus, Javier L.
  • Alfaro Giner, Carmen
  • Piqué Huerta, Raquel
Este artículo está sujeto a una licencia CC BY NC 4.0, Plant material culture can offer unique insights into the ways of life of prehistoric societies; however, its perishable nature has prevented a thorough understanding of its diverse and complex uses. Sites with exceptional preservation of organic materials provide a unique opportunity for further research. The burial site of Cueva de los Murciélagos in southern Iberia, uncovered during 19th-century mining activities, contained the best-preserved hunter-gatherer basketry in southern Europe, together with other unique organic artifacts associated with the first farming communities, such as sandals and a wooden hammer. We present 14 14C dates for the perishable artifacts (N = 76), situating the assemblage between the Early and Middle Holocene (c. 7500 to 4200 cal BCE). Our integrated analysis includes raw material determination and technological and chrono-cultural contextualization of this unique and important set of materials., This work was supported by the project “De los museos al territorio: actualizando el estudio de la Cueva de los Murciélagos de Albuñol (Granada)” (MUTERMUR) (Referencia CM/JIN/2021-009) financed by the program of Young Researchers of Comunidad de Madrid (directed by F.M.-S. as the principal investigator). J.S. is funded by Ramon y Cajal fellowship (RYC2019-028346) by the Spanish Ministry of Science and Innovation (MCIN). M.C. is funded by a Ramón y Cajal fellowship (RYC2019-026697-I) and by the Spanish Ministry of Science and Innovation (MCIN). R.P.H., M.H.-O., and A.P.P. are members of the research group 2021-SGR 00190 funded by the AGAUR. R.P.H. is an ICREA academia researcher. M.M.-S. was funded by the Beatriz Galindo program as Junior Distinguished Researcher (BG20/00076), Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

  • Alvarez Palomo, Belén
  • Gayoso, Jorge
  • Raya, Angel
  • Veiga, Anna
  • Abad Mendez, Maria
  • Vidal Pérez, Francisco
  • Querol Giner, Sergi
  • Garcia Martínez, Iris
Haplobank; Homozigot; Cèl·lules mare pluripotents induïdes, Haplobank; Homocigoto; Células madre pluripotentes inducidas, Haplobank; Homozygous; Induced pluripotent stem cells, Background iPSC (induced pluripotent stem cells) banks of iPSC lines with homozygous HLA (human leukocyte antigen) haplotypes (haplobanks) are proposed as an affordable and off-the-shelf approach to allogeneic transplantation of iPSC derived cell therapies. Cord blood banks offer an extensive source of HLA-typed cells suitable for reprogramming to iPSC. Several initiatives worldwide have been undertaken to create national and international iPSC haplobanks that match a significant part of a population. Methods To create an iPSC haplobank that serves the Spanish population (IPS-PANIA), we have searched the Spanish Bone Marrow Donor Registry (REDMO) to identify the most frequently estimated haplotypes. From the top ten donors identified, we estimated the population coverage using the criteria of zero mismatches in HLA-A, HLA-B, and HLA-DRB1 with different stringencies: high resolution, low resolution, and beneficial mismatch. Results We have calculated that ten cord blood units from homozygous donors stored at the Spanish cord blood banks can provide HLA-A, HLA-B, and HLA-DRB1 matching for 28.23% of the population. Conclusion We confirm the feasibility of using banked cord blood units to create an iPSC haplobank that will cover a significant percentage of the Spanish and international population for future advanced therapy replacement strategies., This research was funded by the Spanish Ministry of Science, Innovation and Universities, National Plan for Scientific and Technical Research and Innovation 2013-2016 RETOS COLABORACIÓN Program 2017: exp. RTC-2017-6000-1. 2017-2021.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

  • Álvarez Palomo, Belén|||0000-0002-3894-044X
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Gayoso, Jorge
  • Raya, Ángel|||0000-0003-2189-9775
  • Veiga, Anna|||0000-0002-0943-9904
  • Abad, María Luisa
  • Eiras, Adolfo
  • Guzmán-Fulgencio, María
  • Luis-Hidalgo, Mar
  • Eguizábal, Cristina
  • Santos, Silvia
  • Balas, Antonio
  • Alenda, Raquel
  • Sanchez-Gordo, Francisco
  • Verdugo, Laura Ponce
  • Villa, Juliana
  • Carreras, Enric|||0000-0002-3134-9964
  • Vidal, Francisco|||0000-0001-8089-4945
  • Madrigal, Alejandro
  • Herrero, María José
  • Rudilla, Francesc|||0000-0002-3099-067X
  • Querol, Sergi|||0000-0002-1105-8633
iPSC (induced pluripotent stem cells) banks of iPSC lines with homozygous HLA (human leukocyte antigen) haplotypes (haplobanks) are proposed as an affordable and off-the-shelf approach to allogeneic transplantation of iPSC derived cell therapies. Cord blood banks offer an extensive source of HLA-typed cells suitable for reprogramming to iPSC. Several initiatives worldwide have been undertaken to create national and international iPSC haplobanks that match a significant part of a population. To create an iPSC haplobank that serves the Spanish population (IPS-PANIA), we have searched the Spanish Bone Marrow Donor Registry (REDMO) to identify the most frequently estimated haplotypes. From the top ten donors identified, we estimated the population coverage using the criteria of zero mismatches in HLA-A, HLA-B, and HLA-DRB1 with different stringencies: high resolution, low resolution, and beneficial mismatch. We have calculated that ten cord blood units from homozygous donors stored at the Spanish cord blood banks can provide HLA-A, HLA-B, and HLA-DRB1 matching for 28.23% of the population. We confirm the feasibility of using banked cord blood units to create an iPSC haplobank that will cover a significant percentage of the Spanish and international population for future advanced therapy replacement strategies. The online version contains supplementary material available at 10.1186/s13287-021-02301-0.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Adapting Cord Blood Collection and Banking Standard Operating Procedures for HLA-Homozygous Induced Pluripotent Stem Cells Production and Banking for Clinical Application

  • Álvarez Palomo, Belén|||0000-0002-3894-044X
  • Vives Armengol, Joaquim|||0000-0001-9719-5235
  • Casaroli-Marano, Ricardo Pedro|||0000-0003-1812-9323
  • G. Gómez, Susana
  • Rodríguez Gómez, Luciano
  • Edel, Michael J.|||0000-0002-5619-8680
  • Querol, Sergi|||0000-0002-1105-8633
In this article, we will discuss the main aspects to be considered to define standard operation procedures (SOPs) for the creation of an induced pluripotent stem cell (iPSC) bank using cord blood (CB)-or similar cell type-bank guidelines for clinical aims. To do this, we adapt the pre-existing SOP for CB banking that can be complementary for iPSCs. Some aspects of iPSC manufacturing and the particular nature of these cells call for special attention, such as the potential multiple applications of the cells, proper explanation to the donor for consent of use, the genomic stability and the risk of genetic privacy disclosure. Some aspects of the iPSC SOP are solidly established by CB banking procedures, other procedures have good consensus in the scientific and medical community, while others still need to be further debated and settled. Given the international sharing vocation of iPSC banking, there is an urgent need by scientists, clinicians and regulators internationally to harmonize standards and allow future sample interchange between many iPSC bank initiatives that are springing up worldwide.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

  • Alvarez Palomo, Belén
  • Gayoso, Jorge
  • Raya, Angel
  • Veiga, Anna
  • Abad Mendez, Maria
  • Vidal Pérez, Francisco
  • Querol Giner, Sergi
  • Garcia Martínez, Iris
Haplobank; Homozigot; Cèl·lules mare pluripotents induïdes, Haplobank; Homocigoto; Células madre pluripotentes inducidas, Haplobank; Homozygous; Induced pluripotent stem cells, Background iPSC (induced pluripotent stem cells) banks of iPSC lines with homozygous HLA (human leukocyte antigen) haplotypes (haplobanks) are proposed as an affordable and off-the-shelf approach to allogeneic transplantation of iPSC derived cell therapies. Cord blood banks offer an extensive source of HLA-typed cells suitable for reprogramming to iPSC. Several initiatives worldwide have been undertaken to create national and international iPSC haplobanks that match a significant part of a population. Methods To create an iPSC haplobank that serves the Spanish population (IPS-PANIA), we have searched the Spanish Bone Marrow Donor Registry (REDMO) to identify the most frequently estimated haplotypes. From the top ten donors identified, we estimated the population coverage using the criteria of zero mismatches in HLA-A, HLA-B, and HLA-DRB1 with different stringencies: high resolution, low resolution, and beneficial mismatch. Results We have calculated that ten cord blood units from homozygous donors stored at the Spanish cord blood banks can provide HLA-A, HLA-B, and HLA-DRB1 matching for 28.23% of the population. Conclusion We confirm the feasibility of using banked cord blood units to create an iPSC haplobank that will cover a significant percentage of the Spanish and international population for future advanced therapy replacement strategies., This research was funded by the Spanish Ministry of Science, Innovation and Universities, National Plan for Scientific and Technical Research and Innovation 2013-2016 RETOS COLABORACIÓN Program 2017: exp. RTC-2017-6000-1. 2017-2021.